Biomedical Engineering Reference
In-Depth Information
29. Keshishian H, Addona T, Burgess M, Mani DR, Shi X, Kuhn E et al (2009) Quantification of
cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope
dilution. Mol Cell Proteomics 8:2339-2349
30. Kuhn E, Addona T, Keshishian H, Burgess M, Mani DR, Lee RT et al (2009) Developing
multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity
enrichment and targeted mass spectrometry. Clin Chem 55:1108-1117
31. Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA (2007) Quantitative, multiplexed
assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope
dilution. Mol Cell Proteomics 6:2212-2229
32. Vogeser M, Seger C (2010) Pitfalls associated with the use of liquid chromatography-tandem
mass spectrometry in the clinical laboratory. Clin Chem 56:1234-1244
33. Allen KR (2006) Interference by venlafaxine ingestion in the detection of tramadol by liquid
chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human
urine. Clin Toxicol 44:147-153
34. Vogeser M, Zachoval R, Spöhrer U, Jacob K (2001) Potential lack of specificity using electro-
spray tandem-mass spectrometry for the analysis of mycophenolic acid in serum. Ther Drug
Monit 23:722-724
35. Vogeser M, Spöhrer U (2005) Pitfall in the high-throughput quantification of whole blood
cyclosporin A using liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med
43:400-402
36. Singh RJ (2008) Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin
D? Clin Chem 54:221-223
37. Carter GD, Jones JC (2009) Use of a common standard improves the performance of liquid
chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann
Clin Biochem 46:79-81
38. Carter GD (2009) 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem
55:1300-1302
39. Kebarle P, Verkerk UH (2009) Electrospray: from ions in solution to ions in the gas phase,
what we know now. Mass Spectrom Rev 28:898-917
40. Covey TR, Thomson BA, Schneider BB (2009) Atmospheric pressure ion sources. Mass
Spectrom Rev 28:870-897
41. Lagerwerf FM, van Dongen WD, Steenvoorden RJJM, Honing M, Jonkman JHG (2000)
Exploring the boundaries of bioanalytical quantitative LC-MS-MS. Trends Anal Chem
19:418-427
42. Annesley TM (2003) Ion suppression in mass spectrometry. Clin Chem 49:1041-1044
43. Taylor PJ (2005) Matrix effects: the Achilles heel of quantitative high-performance liquid
chromatography-electrospray-tandem mass spectrometry. Clin Biochem 38:328-334
44. Keller BO, Sui J, Young AB, Whittal RM (2008) Interferences and contaminants encountered
in modern mass spectrometry. Anal Chim Acta 627:71-81
45. Guo X, Bruins AP, Covey TR (2006) Characterization of typical chemical background inter-
ferences in atmospheric pressure ionization liquid chromatography-mass spectrometry. Rapid
Commun Mass Spectrom 20:3145-3150
46. Gustavsson E, Andersson M, Stephanson N, Beck O (2007) Validation of direct injection elec-
trospray LC-MS/MS for confirmation of opiates in urine drug testing. J Mass Spectrom
42:881-889
47. Thienpont LM, Van Uytfanghe K, Blincko S, Ramsay CS, Xie H, Doss RC et al (2008) State-
of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tan-
dem mass spectrometry. Clin Chem 54:1290-1297
48. Wang S, Cyronak M, Yang E (2007) Does a stable isotopically labeled internal standard always
correct analyte response? A matrix effect study on a LC/MS/MS method for the determination
of carvedilol enantiomers in human plasma. J Pharm Biomed Anal 43:701-707
49. Lindegardh N, Annerberg A, White NJ, Day NP (2008) Development and validation of a liquid
chromatographic-tandem mass spectrometric method for determination of piperaquine in
